Inside with Chris Bateman: When Covid-19 and chemotherapy potentially collide

Loading player...
The deadly threat of Covid-19 multiples when one's immune system is compromised, such as the three million HIV infected individuals not on ARV’s. But a double whammy is in store for those cancer patients who are undergoing chemo-therapy. Not only does chemo kill the white blood cells, whose job it is to keep our immune system working but in addition to this threat lies in the increased potential of contracting the virus. Cancer patients on chemo have no option but to make weekly trips to the hospital, a place where the severely infected need to be. How does someone on chemo right now keep themselves safe? Chris Bateman, a well-known journalist and contributor to Biznews has first hand knowledge on this. Himself a cancer victim currently undergoing chemotherapy Chris tells us how he anticipates a 12-month lockdown, and the extra measures he is taking to keep Covid-19 away from his door. - Vanessa Marks Learn more about your ad choices. Visit megaphone.fm/adchoices
28 Apr 2020 9AM English South Africa Investing · Business News

Other recent episodes

BNC#8 - Restoring power to the people: A call for electoral reform and accountable leadership

This compelling address explores leadership, democracy, and the urgent need for electoral reform in South Africa. Drawing on personal experiences in government and constitutional development, the speaker highlights the growing disconnect between citizens and political representatives. Through powerful stories and reflections, he advocates for a system that empowers individuals to…
29 Mar 8AM 25 min

The NdB Sunday Show: Willem Els - Why terror groups love South Africa

On today’s NdB Sunday Show, Chris Steyn talks to Willem Els, a consultant at the Transnational Threats and Organised Crime and the Justice and Violence Prevention Programme at the Institute for Security Studies (ISS) about why South Africa is considered to be so attractive to terror networks. Els describes how…
29 Mar 5AM 15 min